Tao Xu[Author] - Search Results

Year	Number of Results
1998	1
2001	1
2002	7
2003	12
2004	21
2005	29
2006	28
2007	40
2008	50
2009	54
2010	64
2011	85
2012	119
2013	129
2014	131
2015	149
2016	157
2017	177
2018	211
2019	220
2020	286
2021	336
2022	335
2023	354
2024	137

1

Propofol exerts anti-anhedonia effects via inhibiting the dopamine transporter.

Zhu XN, Li J, Qiu GL, Wang L, Lu C, Guo YG, Yang KX, Cai F, Xu T, Yuan TF, Hu J. Zhu XN, et al. Among authors: xu t. Neuron. 2023 May 17;111(10):1626-1636.e6. doi: 10.1016/j.neuron.2023.02.017. Epub 2023 Mar 13. Neuron. 2023. PMID: 36917979

2

R-loop-dependent promoter-proximal termination ensures genome stability.

Xu C, Li C, Chen J, Xiong Y, Qiao Z, Fan P, Li C, Ma S, Liu J, Song A, Tao B, Xu T, Xu W, Chi Y, Xue J, Wang P, Ye D, Gu H, Zhang P, Wang Q, Xiao R, Cheng J, Zheng H, Yu X, Zhang Z, Wu J, Liang K, Liu YJ, Lu H, Chen FX. Xu C, et al. Among authors: xu t. Nature. 2023 Sep;621(7979):610-619. doi: 10.1038/s41586-023-06515-5. Epub 2023 Aug 9. Nature. 2023. PMID: 37557913 Free PMC article.

3

Single-cell transcriptomic atlas-guided development of CAR-T cells for the treatment of acute myeloid leukemia.

Gottschlich A, Thomas M, Grünmeier R, Lesch S, Rohrbacher L, Igl V, Briukhovetska D, Benmebarek MR, Vick B, Dede S, Müller K, Xu T, Dhoqina D, Märkl F, Robinson S, Sendelhofert A, Schulz H, Umut Ö, Kavaka V, Tsiverioti CA, Carlini E, Nandi S, Strzalkowski T, Lorenzini T, Stock S, Müller PJ, Dörr J, Seifert M, Cadilha BL, Brabenec R, Röder N, Rataj F, Nüesch M, Modemann F, Wellbrock J, Fiedler W, Kellner C, Beltrán E, Herold T, Paquet D, Jeremias I, von Baumgarten L, Endres S, Subklewe M, Marr C, Kobold S. Gottschlich A, et al. Among authors: xu t. Nat Biotechnol. 2023 Nov;41(11):1618-1632. doi: 10.1038/s41587-023-01684-0. Epub 2023 Mar 13. Nat Biotechnol. 2023. PMID: 36914885 Free PMC article.

4

Stiffness Restricts the Stemness of the Intestinal Stem Cells and Skews Their Differentiation Toward Goblet Cells.

He S, Lei P, Kang W, Cheung P, Xu T, Mana M, Park CY, Wang H, Imada S, Russell JO, Wang J, Wang R, Zhou Z, Chetal K, Stas E, Mohad V, Bruun-Rasmussen P, Sadreyev RI, Hodin RA, Zhang Y, Breault DT, Camargo FD, Yilmaz ÖH, Fredberg JJ, Saeidi N. He S, et al. Among authors: xu t. Gastroenterology. 2023 Jun;164(7):1137-1151.e15. doi: 10.1053/j.gastro.2023.02.030. Epub 2023 Mar 4. Gastroenterology. 2023. PMID: 36871599

5

Lateral septum adenosine A_2A receptors control stress-induced depressive-like behaviors via signaling to the hypothalamus and habenula.

Wang M, Li P, Li Z, da Silva BS, Zheng W, Xiang Z, He Y, Xu T, Cordeiro C, Deng L, Dai Y, Ye M, Lin Z, Zhou J, Zhou X, Ye F, Cunha RA, Chen J, Guo W. Wang M, et al. Among authors: xu t. Nat Commun. 2023 Apr 5;14(1):1880. doi: 10.1038/s41467-023-37601-x. Nat Commun. 2023. PMID: 37019936 Free PMC article.

6

SIRT1 attenuates blood-spinal cord barrier disruption after spinal cord injury by deacetylating p66Shc.

Jiang T, Qin T, Gao P, Tao Z, Wang X, Wu M, Gu J, Chu B, Zheng Z, Yi J, Xu T, Huang Y, Liu H, Zhao S, Ren Y, Chen J, Yin G. Jiang T, et al. Among authors: xu t. Redox Biol. 2023 Apr;60:102615. doi: 10.1016/j.redox.2023.102615. Epub 2023 Jan 24. Redox Biol. 2023. PMID: 36716673 Free PMC article.

7

IQGAP1 promotes mitochondrial damage and activation of the mtDNA sensor cGAS-STING pathway to induce endothelial cell pyroptosis leading to atherosclerosis.

An C, Sun F, Liu C, Huang S, Xu T, Zhang C, Ge S. An C, et al. Among authors: xu t. Int Immunopharmacol. 2023 Oct;123:110795. doi: 10.1016/j.intimp.2023.110795. Epub 2023 Aug 17. Int Immunopharmacol. 2023. PMID: 37597406

8

Decorin: a potential therapeutic candidate for ligamentum flavum hypertrophy by antagonizing TGF-β1.

Wang S, Qu Y, Fang X, Ding Q, Zhao H, Yu X, Xu T, Lu R, Jing S, Liu C, Wu H, Liu Y. Wang S, et al. Among authors: xu t. Exp Mol Med. 2023 Jul;55(7):1413-1423. doi: 10.1038/s12276-023-01023-y. Epub 2023 Jul 3. Exp Mol Med. 2023. PMID: 37394592 Free PMC article.

9

Harnessing immunotherapy for brain metastases: insights into tumor-brain microenvironment interactions and emerging treatment modalities.

Zhou D, Gong Z, Wu D, Ma C, Hou L, Niu X, Xu T. Zhou D, et al. Among authors: xu t. J Hematol Oncol. 2023 Dec 16;16(1):121. doi: 10.1186/s13045-023-01518-1. J Hematol Oncol. 2023. PMID: 38104104 Free PMC article. Review.

10

CCL2 is a key regulator and therapeutic target for periodontitis.

Jiang W, Xu T, Song Z, Wang X, Yuan S, Li Q, Wei Y, Wang C, Yang G, Cao J, Mo Y, Liu Z, Li N, Li S, Lv P, Zhang Y, Wang Y, Hu W. Jiang W, et al. Among authors: xu t. J Clin Periodontol. 2023 Dec;50(12):1644-1657. doi: 10.1111/jcpe.13872. Epub 2023 Sep 11. J Clin Periodontol. 2023. PMID: 37697486

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

2,807 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

2,807 results

Results by year